Louise Frederika Kooij New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

NAMS Quotes by TradingView
Shares Held (Direct Ownership) 15K
0% 3M change
Infinity% 12M change
Total Value Held N/A

Louise Frederika Kooij Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2025
SELL
Open market or private sale
$1,548,681 $35.3 p/Share
43,872 Reduced 74.52%
15,000 Ordinary Shares
Dec 26 2025
BUY
Exercise of conversion of derivative security
$458,462 $10.45 p/Share
43,872 Added 42.7%
58,872 Ordinary Shares
Dec 24 2025
SELL
Open market or private sale
$928,072 $35.68 p/Share
26,011 Reduced 63.42%
15,000 Ordinary Shares
Dec 24 2025
BUY
Exercise of conversion of derivative security
$260,110 $10.0 p/Share
26,011 Added 38.81%
41,011 Ordinary Shares
Dec 23 2025
SELL
Open market or private sale
$2,719,986 $36.21 p/Share
75,117 Reduced 83.35%
15,000 Ordinary Shares
Dec 23 2025
BUY
Exercise of conversion of derivative security
$751,170 $10.0 p/Share
75,117 Added 45.46%
90,117 Ordinary Shares
Sep 09 2025
SELL
Open market or private sale
$3,856,500 $25.71 p/Share
150,000 Reduced 90.91%
15,000 Ordinary Shares
Sep 09 2025
BUY
Exercise of conversion of derivative security
$1,500,000 $10.0 p/Share
150,000 Added 47.62%
165,000 Ordinary Shares
Sep 03 2025
SELL
Open market or private sale
$453,451 $25.09 p/Share
18,073 Reduced 54.65%
15,000 Ordinary Shares
Sep 02 2025
BUY
Exercise of conversion of derivative security
-
18,073 Added 35.34%
33,073 Ordinary Shares
Aug 25 2025
SELL
Open market or private sale
$205,567 $24.86 p/Share
8,269 Reduced 35.54%
15,000 Ordinary Shares
Mar 26 2025
BUY
Exercise of conversion of derivative security
-
8,269 Added 26.22%
23,269 Ordinary Shares
Mar 04 2025
SELL
Open market or private sale
$3,055,500 $20.37 p/Share
150,000 Reduced 90.91%
15,000 Ordinary Shares
Mar 04 2025
BUY
Exercise of conversion of derivative security
-
150,000 Added 47.62%
165,000 Ordinary Shares
Jan 07 2025
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Ordinary Shares
Oct 01 2024
SELL
Open market or private sale
$707,400 $15.72 p/Share
45,000 Reduced 100.0%
0 Ordinary Shares
Sep 27 2024
BUY
Exercise of conversion of derivative security
-
45,000 Added 50.0%
45,000 Ordinary Shares
LFK

Louise Frederika Kooij

Chief Accounting Officer
Naarden, P7

Track Institutional and Insider Activities on NAMS

Follow NewAmsterdam Pharma Co N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Insider Trading

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

News

Receive news related to NewAmsterdam Pharma Co N.V.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAMS